Insulin Resistance and Androgen Deprivation Therapy

NCT04995978 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped No participants were recruited and the study was deemed not feasible

Conditions

Prostate Cancer
Insulin Resistance

Interventions

DRUG: Pioglitazone 30 mg
DRUG: placebo tablet

Sponsor

St. Louis University